{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

A survey to assess the usage pattern of etifoxine in the management of Anxiety in India

Survey Questionnaire Form
Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. How many patients of anxiety do you see in a month? *

  2. In your clinical practice anxiety in commonly found in? *

  3. In your clinical experience, anxiety is more commonly diagnosed in which age group of patients? *

  4. How often do you encounter anxiety cases in your practice? *

  5. In your clinical practice what is / are the most common cause/ causes of anxiety? *
  6. In your clinical practice how do evaluate/screen the patient for anxiety? *

  7. In your clinical practice how do you manage patients (Do you follow some guidelines or by clinical experience) of anxiety? *

  8. Which is your preferred choice of drug for treatment of anxiety? *

  9. What are the side effects of benzodiazepines? *

  10. What are the challenges you face while treating patients of anxiety with Benzodiazepines? *

  11. What are the challenges you face while treating patients of anxiety with SSRI’s? *

  12. As per your clinical experience, which factors are critical for choosing first-line treatment option in the management of anxiety? *

  13. Do you prescribe etifoxine for anxiety? *

  14. Have you prescribed etifoxine for managing anxiety in the past 1 month? *

  15. In which anxiety disorders (GAD, SAD, Panic attacks etc.) have you prescribed etifoxine *
  16. What is the typical starting dose of etifoxine you prescribe for adult patients with anxiety? *

  17. What is the maintenance dose of etifoxine you prescribe for adult patients with anxiety? *

  18. What is the mechanism of action etifoxine? *

  19. In your experience, how long does it usually take for patients to experience symptom improvement etifoxine? *

  20. Do you prescribe etifoxine as monotherapy or as add-on or along with benzodiazepines for management of anxiety? *

  21. Time interval of etifoxine dose titration for response optimization in your clinical practice? *

  22. What are the advantages of etifoxine over benzodiazepine? *

  23. How often do you schedule follow-up appointments with patients after initiating etifoxine? *

  24. How do you assess disease progression and treatment response in patients of anxiety? *

  25. Do you recommend lifestyle modifications in conjunction with etifoxine, (please specify what lifestyle modification)? *
  26. What strategies do you use to enhance patient adherence to etifoxine? *

  27. In your clinical practice do you prescribe etifoxine in anxiety patients with comorbidities? *

  28. Based on your clinical experience, knowledge and practice, what are the potential reasons for choosing etifoxine over benzodiazepines/ SSRI’s?*
  29. In your experience, how effective is etifoxine in reducing psychosomatic symptoms in anxiety? *

  30. In your opinion what are the factors which most commonly contribute to medication non-adherence in anxiety patients? *
  31. Mention some initial instructions/advice you give to your patients before initiating the etifoxine for the treatment of anxiety? *
  32. What insights or recommendations would you offer to fellow psychiatrist/ Neurologist regarding use of etifoxine in anxiety management?*
  33. What are your thoughts on the efficacy and overall tolerability of etifoxine compared to benzodiazepines in the management of anxiety? *